INVO Fertility, Inc. (IVF) is the 298th largest of 300 Healthcare Services companies by market capitalisation, at 2.01 Mn, behind Cardiff Lexington Corp at 2.39 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DVA | Davita Inc. | primary | H-14 | Healthcare Providers | HG-04 | 11.99 Bn | 10.29 | 0.86 | 11.30 Bn |
| 2 | RDNT | RadNet, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 5.56 Bn | 289.00 | 2.45 | 4.83 Bn |
| 3 | FMCQF | Fresenius Medical Care AG | primary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 4 | CON | Concentra Group Holdings Parent, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 4.26 Bn | 20.74 | 1.86 | 4.11 Bn |
| 5 | PRVA | Privia Health Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.57 Bn | 76.15 | 1.09 | 2.16 Bn |
| 6 | PGNY | Progyny, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.12 Bn | 27.00 | 1.62 | 1.88 Bn |
| 7 | MD | Pediatrix Medical Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 2.12 Bn | 12.12 | 1.09 | 1.72 Bn |
| 8 | SGRY | Surgery Partners, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 1.84 Bn | 22.46 | 0.55 | 1.62 Bn |
| 9 | USPH | U S Physical Therapy Inc /Nv | primary | H-14 | Healthcare Providers | HG-04 | 1.18 Bn | 23.63 | 1.45 | 1.15 Bn |
| 10 | EVH | Evolent Health, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.48 Bn | -0.94 | 0.23 | 0.34 Bn |
| 11 | SRTA | Strata Critical Medical, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.46 Bn | 11.37 | 1.79 | 0.43 Bn |
| 12 | SBC | SBC Medical Group Holdings Inc | primary | H-14 | Healthcare Providers | HG-04 | 0.45 Bn | 11.82 | 2.55 | 0.26 Bn |
| 13 | INFU | InfuSystem Holdings, Inc | primary | H-14 | Healthcare Providers | HG-04 | 0.24 Bn | 28.32 | 1.69 | 0.24 Bn |
| 14 | AIRS | Airsculpt Technologies, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.18 Bn | -15.69 | 1.22 | 0.16 Bn |
| 15 | JYNT | JOINT Corp | primary | H-14 | Healthcare Providers | HG-04 | 0.11 Bn | 30.67 | 1.96 | 0.09 Bn |
| 16 | RYOJ | rYojbaba Co., Ltd. | primary | H-14 | Healthcare Providers | HG-04 | 0.05 Bn | -47.64 | 6.80 | 0.05 Bn |
| 17 | BTMD | biote Corp. | primary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | 6.41 | 0.23 | 0.03 Bn |
| 18 | DCGO | DocGo Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | -0.18 | 0.12 | 0.01 Bn |
| 19 | PIII | P3 Health Partners Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.03 Bn | -0.11 | 0.02 | 0.01 Bn |
| 20 | EUDA | EUDA Health Holdings Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -9.10 | 3.74 | 0.02 Bn |
| 21 | SY | So-Young International Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -0.58 | 0.08 | -0.09 Bn |
| 22 | LDDD | Longduoduo Co Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -35.14 | 7.18 | 0.01 Bn |
| 23 | AMS | American Shared Hospital Services | primary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | -3.84 | 0.33 | 0.00 Bn |
| 24 | BMGL | Basel Medical Group Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | 10.57 | — | 0.01 Bn |
| 25 | STLNW | Starling Oncology, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | -0.17 | 0.01 | -0.04 Bn |
| 26 | LFST | LifeStance Health Group, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.09 | 0.00 | -0.22 Bn |
| 27 | CDIX | Cardiff Lexington Corp | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | — | — | 0.01 Bn |
| 28 | IVF | INVO Fertility, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.34 | 0.45 | 0.00 Bn |
| 29 | FCHS | First Choice Healthcare Solutions, Inc. | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.05 | — | 0.00 Bn |
| 30 | NIVF | NewGenIvf Group Ltd | primary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.00 | 0.00 | 0.00 Bn |
| 31 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 647.54 Bn | 30.78 | 6.61 | 626.78 Bn |
| 32 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 441.45 Bn | 69.89 | 6.86 | 434.88 Bn |
| 33 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.78 Bn | 115.11 | 5.48 | 357.64 Bn |
| 34 | UNH | Unitedhealth Group Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 352.37 Bn | 23.63 | 0.78 | 320.90 Bn |
| 35 | AMGN | Amgen Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 211.88 Bn | 24.23 | 5.56 | 197.89 Bn |
| 36 | ABT | Abbott Laboratories | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 184.57 Bn | 34.02 | 3.96 | 178.97 Bn |
| 37 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 181.55 Bn | -62.71 | 5.96 | 178.37 Bn |
| 38 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.31 Bn | 30.03 | 10.51 | 124.45 Bn |
| 39 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 124.13 Bn | 39.31 | 11.25 | 118.91 Bn |
| 40 | CVS | CVS HEALTH Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 122.23 Bn | 25.02 | 0.29 | 108.27 Bn |
| 41 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 118.29 Bn | 22.44 | 3.15 | 109.47 Bn |
| 42 | HCA | HCA Healthcare, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 91.44 Bn | 11.67 | 1.17 | 90.42 Bn |
| 43 | REGN | Regeneron Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 82.51 Bn | 19.06 | 5.31 | 74.52 Bn |
| 44 | BSX | Boston Scientific Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 66.50 Bn | 18.10 | 3.17 | 65.97 Bn |
| 45 | ARGX | Argenx Se | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 61.54 Bn | 35.88 | 11.78 | 56.36 Bn |
| 46 | TEL | TE Connectivity plc | secondary | I-07 | Machinery | IG-02 | 59.54 Bn | 19.29 | 3.08 | 58.30 Bn |
| 47 | MRNA | Moderna, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 54.69 Bn | -17.36 | 24.55 | 49.55 Bn |
| 48 | AME | Ametek Inc/ | secondary | I-04 | Machinery | IG-02 | 54.32 Bn | 34.46 | 6.91 | 53.82 Bn |
| 49 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.54 Bn | 11.27 | 0.98 | 45.16 Bn |
| 50 | EW | Edwards Lifesciences Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 49.72 Bn | 49.54 | 7.63 | 45.46 Bn |
| 51 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 49.38 Bn | 52.42 | 2.12 | 48.51 Bn |
| 52 | HUM | Humana Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 48.22 Bn | 35.14 | 0.33 | 24.35 Bn |
| 53 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.93 Bn | 61.68 | 2.48 | 39.28 Bn |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 34.07 Bn | 43.98 | 7.09 | 30.76 Bn |
| 55 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.97 Bn | 52.83 | 3.16 | 32.51 Bn |
| 56 | DXCM | Dexcom Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 32.23 Bn | 32.24 | 6.49 | 30.29 Bn |
| 57 | CNC | Centene Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 31.74 Bn | -6.22 | 0.16 | 4.68 Bn |
| 58 | BIIB | Biogen Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 31.41 Bn | 37.63 | 3.13 | 30.12 Bn |
| 59 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.10 Bn | -20.28 | 2,755.62 | 30.10 Bn |
| 60 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.92 Bn | 14.59 | 1.41 | 27.81 Bn |
| 61 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.83 Bn | -31.80 | 24.46 | 26.67 Bn |
| 62 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.36 Bn | 15.73 | 4.36 | 20.82 Bn |
| 63 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.92 Bn | 43.54 | 7.19 | 23.48 Bn |
| 64 | BNTX | BioNTech SE | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 23.55 Bn | -13.82 | 7.61 | 9.89 Bn |
| 65 | THC | Tenet Healthcare Corp | secondary | H-13 | Healthcare Providers | HG-04 | 22.17 Bn | 9.89 | 1.02 | 20.00 Bn |
| 66 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.16 Bn | 26.19 | 3.50 | 20.68 Bn |
| 67 | ZBH | Zimmer Biomet Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 18.18 Bn | 21.46 | 2.14 | 17.77 Bn |
| 68 | NDSN | Nordson Corp | secondary | I-04 | Machinery | IG-02 | 17.48 Bn | 31.49 | 5.87 | 17.37 Bn |
| 69 | FTV | Fortive Corp | secondary | I-04 | Machinery | IG-02 | 17.13 Bn | 32.06 | 3.97 | 16.76 Bn |
| 70 | IEX | Idex Corp /De/ | secondary | I-10 | Machinery | IG-02 | 16.71 Bn | 32.18 | 4.66 | 16.09 Bn |
| 71 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.41 Bn | 11.76 | 0.93 | 15.66 Bn |
| 72 | ASND | Ascendis Pharma A/S | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 15.96 Bn | 18.40 | 11.26 | 15.01 Bn |
| 73 | MDGL | Madrigal Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 15.83 Bn | -49.63 | 12.33 | 14.99 Bn |
| 74 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.53 Bn | 22.02 | 4.60 | 15.15 Bn |
| 75 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.48 Bn | 10.79 | 1.86 | 15.08 Bn |
| 76 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.13 Bn | 16.08 | 3.29 | 13.51 Bn |
| 77 | BBIO | BridgeBio Pharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 14.67 Bn | -21.20 | 20.57 | 13.95 Bn |
| 78 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.41 Bn | 16.75 | 5.92 | 13.57 Bn |
| 79 | SMMT | Summit Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 13.50 Bn | — | — | 12.81 Bn |
| 80 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 13.12 Bn | 55.63 | 3.10 | 12.98 Bn |
| 81 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.81 Bn | 557.12 | 1.15 | 10.66 Bn |
| 82 | HALO | Halozyme Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.59 Bn | 30.45 | 7.57 | 12.36 Bn |
| 83 | PEN | Penumbra Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 12.58 Bn | 78.39 | 8.36 | 11.93 Bn |
| 84 | BMRN | Biomarin Pharmaceutical Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.52 Bn | 171.54 | 3.67 | 11.64 Bn |
| 85 | ARWR | Arrowhead Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.10 Bn | -44.46 | 18.07 | 10.50 Bn |
| 86 | MOG-A | Moog Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 11.65 Bn | 30.90 | 2.70 | 11.59 Bn |
| 87 | AAVXF | Abivax S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.92 Bn | -25.97 | — | 10.92 Bn |
| 88 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.88 Bn | -70.79 | 14.01 | 10.56 Bn |
| 89 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.68 Bn | -67.82 | 17.43 | 10.57 Bn |
| 90 | UHS | Universal Health Services Inc | secondary | H-13 | Healthcare Providers | HG-04 | 10.36 Bn | 6.79 | 0.57 | 10.22 Bn |
| 91 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.20 Bn | -26.74 | — | 9.44 Bn |
| 92 | APGE | Apogee Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.18 Bn | -34.62 | — | 9.20 Bn |
| 93 | GMED | Globus Medical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.08 Bn | 18.83 | 3.21 | 9.49 Bn |
| 94 | RDY | Dr Reddys Laboratories Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.86 Bn | 781.50 | 2.69 | 9.69 Bn |
| 95 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.69 Bn | 25.82 | 3.17 | 9.16 Bn |
| 96 | PTGX | Protagonist Therapeutics, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.61 Bn | 86.99 | 34.06 | 9.61 Bn |
| 97 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.41 Bn | -50.01 | — | 9.41 Bn |
| 98 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.24 Bn | -43.53 | 10.57 | 7.18 Bn |
| 99 | PCVX | Vaxcyte, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.60 Bn | -8.14 | — | 8.60 Bn |
| 100 | IBRX | ImmunityBio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.46 Bn | -8.52 | 51.02 | 8.10 Bn |
| 101 | IMVT | Immunovant, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.02 Bn | -14.89 | — | 8.02 Bn |
| 102 | TGTX | Tg Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.76 Bn | 17.57 | 9.71 | 7.08 Bn |
| 103 | ATR | Aptargroup, Inc. | secondary | I-04 | Machinery | IG-02 | 7.74 Bn | 21.33 | 1.97 | 7.54 Bn |
| 104 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 105 | SYRE | Spyre Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.48 Bn | -41.79 | — | 7.48 Bn |
| 106 | HNGE | Hinge Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 7.27 Bn | 67.72 | 10.10 | 6.88 Bn |
| 107 | SRRK | Scholar Rock Holding Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.18 Bn | -17.78 | — | 7.18 Bn |
| 108 | RYTM | Rhythm Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.88 Bn | -32.74 | 28.69 | 6.55 Bn |
| 109 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.43 Bn | -39.46 | 1.21 | 6.05 Bn |
| 110 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.39 Bn | -20.47 | 2.00 | 6.18 Bn |
| 111 | CGON | CG Oncology, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.38 Bn | -28.49 | 1,025.18 | 6.38 Bn |
| 112 | MIRM | Mirum Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.34 Bn | -7.37 | 10.26 | 5.90 Bn |
| 113 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.30 Bn | -703.30 | 4,524.98 | 6.30 Bn |
| 114 | KNSA | Kiniksa Pharmaceuticals International, plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.20 Bn | 76.84 | 7.37 | 5.67 Bn |
| 115 | NOVT | Novanta Inc | secondary | I-04 | Machinery | IG-02 | 6.01 Bn | 113.68 | 5.84 | 5.30 Bn |
| 116 | COGT | Cogent Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.98 Bn | -16.17 | — | 5.98 Bn |
| 117 | TFX | Teleflex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.97 Bn | -5.30 | 2.65 | 5.67 Bn |
| 118 | ORKA | Oruka Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.86 Bn | — | — | 4.13 Bn |
| 119 | XENE | Xenon Pharmaceuticals Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.86 Bn | -16.15 | — | 5.86 Bn |
| 120 | DBVT | DBV Technologies S.A. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.84 Bn | -33.17 | 1,163.09 | 5.66 Bn |
| 121 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.80 Bn | 29.39 | 19.95 | 4.44 Bn |
| 122 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.65 Bn | 36.00 | 3.96 | 5.54 Bn |
| 123 | PTCT | Ptc Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.62 Bn | 14.70 | 5.57 | 3.39 Bn |
| 124 | MMSI | Merit Medical Systems Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.20 Bn | 35.74 | 3.29 | 4.75 Bn |
| 125 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.04 Bn | -17.55 | — | 5.04 Bn |
| 126 | CELC | Celcuity Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.03 Bn | -22.99 | — | 5.03 Bn |
| 127 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.65 Bn | 48.25 | 3.44 | 4.42 Bn |
| 128 | LIVN | LivaNova PLC | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.33 Bn | 22.87 | 2.95 | 3.82 Bn |
| 129 | ITGR | Integer Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.30 Bn | 33.48 | 2.33 | 4.28 Bn |
| 130 | ICUI | Icu Medical Inc/De | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.06 Bn | 121.57 | 1.88 | 3.76 Bn |
| 131 | DNTH | Dianthus Therapeutics, Inc. /DE/ | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.04 Bn | — | — | 3.63 Bn |
| 132 | PLSE | Pulse Biosciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.02 Bn | -49.89 | 5,131.30 | 4.02 Bn |
| 133 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.02 Bn | -7.86 | 1,115.68 | 4.02 Bn |
| 134 | IRTC | iRhythm Holdings, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.98 Bn | -285.48 | 4.82 | 3.39 Bn |
| 135 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -521.64 | 4.64 | 3.59 Bn |
| 136 | VKTX | Viking Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.86 Bn | -7.21 | — | 3.86 Bn |
| 137 | IOVA | Iovance Biotherapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.86 Bn | -18.46 | 11.87 | 3.56 Bn |
| 138 | RLAY | Relay Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | -13.47 | 372.09 | 3.85 Bn |
| 139 | AMLX | Amylyx Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.69 Bn | -30.34 | — | 3.69 Bn |
| 140 | OPCH | Option Care Health, Inc. | secondary | H-15 | Healthcare Providers | HG-04 | 3.60 Bn | 17.19 | 0.63 | 3.41 Bn |
| 141 | TNGX | Tango Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.60 Bn | -35.16 | 66.87 | 2.58 Bn |
| 142 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.58 Bn | -7.79 | 30.62 | 2.88 Bn |
| 143 | IDYA | IDEAYA Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.54 Bn | -16.08 | 15.12 | 2.71 Bn |
| 144 | RSMDF | Resmed Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.54 Bn | 2.34 | 0.63 | 2.07 Bn |
| 145 | CRVL | Corvel Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 3.40 Bn | — | — | 3.06 Bn |
| 146 | ABCL | AbCellera Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.39 Bn | -20.57 | 51.19 | 3.39 Bn |
| 147 | IPGP | Ipg Photonics Corp | secondary | I-04 | Machinery | IG-02 | 3.37 Bn | 122.16 | 3.15 | 2.50 Bn |
| 148 | DYN | Dyne Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.23 Bn | -6.26 | — | 3.23 Bn |
| 149 | ARQT | Arcutis Biotherapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.14 Bn | 110.36 | 6.78 | 2.91 Bn |
| 150 | TMDX | TransMedics Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.02 Bn | 17.62 | 4.51 | 2.55 Bn |
| 151 | CLDX | Celldex Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.01 Bn | -9.80 | 19,070.80 | 3.01 Bn |
| 152 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.99 Bn | -11.06 | 593.06 | 2.47 Bn |
| 153 | MBX | MBX Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.96 Bn | -28.43 | — | 2.96 Bn |
| 154 | IRON | Disc Medicine, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.94 Bn | -14.62 | — | 2.94 Bn |
| 155 | WRBY | Warby Parker Inc. | secondary | D-10 | Apparel and Luxury | DG-04 | 2.93 Bn | 378.51 | 3.21 | 2.64 Bn |
| 156 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.92 Bn | -8.55 | 79.36 | 2.47 Bn |
| 157 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.83 Bn | -15.03 | 6.29 | 2.12 Bn |
| 158 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.72 Bn | -22.95 | 2.08 | 2.63 Bn |
| 159 | ALHC | Alignment Healthcare, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.65 Bn | 65.22 | 0.58 | 1.95 Bn |
| 160 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.63 Bn | -81.01 | — | 2.63 Bn |
| 161 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | 4.56 | 0.06 | -3.18 Bn |
| 162 | CHRN | ChronoScale Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.60 Bn | -55.84 | 41.09 | 2.59 Bn |
| 163 | ATRC | AtriCure, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.60 Bn | 246.06 | 4.56 | 2.43 Bn |
| 164 | ACHC | Acadia Healthcare Company, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 2.57 Bn | -2.94 | 0.76 | 2.40 Bn |
| 165 | OCUL | Ocular Therapeutix, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.54 Bn | -8.40 | 48.85 | 2.54 Bn |
| 166 | AXGN | Axogen, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.54 Bn | -171.60 | 10.11 | 2.43 Bn |
| 167 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 168 | VERA | Vera Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.47 Bn | -6.17 | — | 2.47 Bn |
| 169 | NKTR | Nektar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.45 Bn | -20.61 | 44.88 | 1.77 Bn |
| 170 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.61 | 3.09 | 2.06 Bn |
| 171 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.43 Bn | 13.64 | 2.53 | 1.63 Bn |
| 172 | VRDN | Viridian Therapeutics, Inc.\DE | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.42 Bn | -6.05 | 34.03 | 2.42 Bn |
| 173 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | -2.18 | 0.22 | 0.55 Bn |
| 174 | SRPT | Sarepta Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.35 Bn | -17.11 | 1.19 | 1.55 Bn |
| 175 | URGN | UroGen Pharma Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.33 Bn | -37.44 | 12.35 | 2.22 Bn |
| 176 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.31 Bn | -5.99 | 4.31 | 1.95 Bn |
| 177 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -21.22 | 13.51 | 2.29 Bn |
| 178 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.25 Bn | -3.84 | — | 1.99 Bn |
| 179 | ESTA | Establishment Labs Holdings Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.23 Bn | -57.30 | 9.07 | 2.16 Bn |
| 180 | PHVS | Pharvaris N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.22 Bn | -11.19 | — | 1.85 Bn |
| 181 | UFPT | Ufp Technologies Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.17 Bn | 29.98 | 3.43 | 2.16 Bn |
| 182 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.16 Bn | 12.97 | 4.21 | 2.02 Bn |
| 183 | GMAB | Genmab A/S | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.16 Bn | 0.17 | 0.34 | 0.65 Bn |
| 184 | XTLB | Xtl Biopharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.15 Bn | -2,975.41 | — | 2.15 Bn |
| 185 | KOD | Kodiak Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.14 Bn | -8.84 | — | 2.14 Bn |
| 186 | RAPP | Rapport Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.12 Bn | -15.43 | 105.83 | 2.12 Bn |
| 187 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.67 | 6.73 | 1.65 Bn |
| 188 | AGIO | Agios Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.07 Bn | -5.03 | 21.06 | 2.07 Bn |
| 189 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.05 Bn | -4.92 | 2,045.15 | 2.05 Bn |
| 190 | ZYME | Zymeworks Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.00 Bn | -13.35 | 53.95 | 1.73 Bn |
| 191 | CMPS | COMPASS Pathways plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.99 Bn | -5.05 | — | 1.99 Bn |
| 192 | VCEL | Vericel Corp | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.98 Bn | 79.10 | 6.48 | 1.82 Bn |
| 193 | STOK | Stoke Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.96 Bn | -9.43 | 71.00 | 1.67 Bn |
| 194 | XNCR | Xencor Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.92 Bn | -11.75 | 18.28 | 1.54 Bn |
| 195 | INBX | Inhibrx Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.92 Bn | -14.36 | 1,473.61 | 1.92 Bn |
| 196 | INSP | Inspire Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.90 Bn | 14.10 | 2.12 | 1.58 Bn |
| 197 | NVCR | NovoCure Ltd | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.90 Bn | -12.81 | 2.72 | 1.46 Bn |
| 198 | ASTH | Astrana Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.86 Bn | 53.14 | 0.48 | 1.46 Bn |
| 199 | LMAT | Lemaitre Vascular Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.81 Bn | 27.63 | 6.91 | 1.44 Bn |
| 200 | VIR | Vir Biotechnology, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.81 Bn | -7.20 | 5.97 | 1.81 Bn |
| 201 | SNDX | Syndax Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.77 Bn | -9.78 | 7.03 | 1.22 Bn |
| 202 | IMCR | Immunocore Holdings plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.76 Bn | -97.45 | 4.09 | 0.88 Bn |
| 203 | SEPN | Septerna, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.74 Bn | -124.42 | 17.57 | 1.74 Bn |
| 204 | GLPGF | Lakefront Biotherapeutics NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.73 Bn | 0.00 | 1.50 | 1.73 Bn |
| 205 | BLFS | Biolife Solutions Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.73 Bn | 29.79 | 16.79 | 1.64 Bn |
| 206 | RXRX | Recursion Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.72 Bn | -3.31 | 31.35 | 1.17 Bn |
| 207 | DMRA | Damora Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.65 Bn | -6.27 | — | 1.11 Bn |
| 208 | GHRS | GH Research PLC | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.64 Bn | -26.30 | — | 1.28 Bn |
| 209 | BCAX | Bicara Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.61 Bn | -8.70 | — | 1.61 Bn |
| 210 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.61 Bn | -6.49 | 3.88 | 0.89 Bn |
| 211 | ANAB | Anaptysbio, Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.60 Bn | -66.91 | 8.02 | 1.31 Bn |
| 212 | ATAI | AtaiBeckley Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.59 Bn | -10.35 | 524.82 | 1.59 Bn |
| 213 | FBRX | Forte Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.58 Bn | -20.71 | — | 1.23 Bn |
| 214 | INNV | InnovAge Holding Corp. | secondary | H-15 | Healthcare Providers | HG-04 | 1.57 Bn | -101.19 | 1.66 | 1.44 Bn |
| 215 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | -186.21 | 905.74 | 1.56 Bn |
| 216 | AGL | agilon health, inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.54 Bn | -6.65 | 0.26 | 1.36 Bn |
| 217 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 20.12 | 1.26 Bn |
| 218 | ARDT | Ardent Health, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.54 Bn | 9.14 | 0.24 | 0.82 Bn |
| 219 | OMCL | Omnicell, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.52 Bn | 38.81 | 1.22 | 1.22 Bn |
| 220 | ANRO | Alto Neuroscience, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | -18.03 | — | 1.51 Bn |
| 221 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | -3.23 | 2.08 | 1.20 Bn |
| 222 | HCSG | Healthcare Services Group Inc | secondary | I-27 | Business Services | IG-06 | 1.49 Bn | 12.10 | 0.80 | 1.32 Bn |
| 223 | MAZE | Maze Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -13.93 | 73.88 | 1.48 Bn |
| 224 | GLUE | Monte Rosa Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -9.45 | 50.66 | 0.82 Bn |
| 225 | ATEC | Alphatec Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.45 Bn | -13.20 | 1.78 | 1.33 Bn |
| 226 | SDGR | Schrodinger, Inc. | secondary | T-27 | Vertical Software | TG-05 | 1.44 Bn | -26.51 | 5.56 | 1.03 Bn |
| 227 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -8.68 | — | 1.42 Bn |
| 228 | REPL | Replimune Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -4.75 | — | 1.41 Bn |
| 229 | CNMD | CONMED Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.41 Bn | 24.91 | 1.03 | 1.37 Bn |
| 230 | TYRA | Tyra Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.39 Bn | -9.37 | — | 1.39 Bn |
| 231 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.63 | 35.82 | 1.38 Bn |
| 232 | ABSI | Absci Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.37 Bn | -11.35 | 880.17 | 1.17 Bn |
| 233 | SVRA | Savara Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.36 Bn | -9.79 | — | 1.36 Bn |
| 234 | NUTX | Nutex Health Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.36 Bn | 4.99 | 1.61 | 1.15 Bn |
| 235 | KMTS | Kestra Medical Technologies, Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.35 Bn | -10.25 | 14.19 | 0.99 Bn |
| 236 | ORIC | Oric Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.34 Bn | -8.55 | — | 1.34 Bn |
| 237 | EYE | National Vision Holdings, Inc. | secondary | D-36 | Retail | DG-10 | 1.34 Bn | 48.25 | 0.68 | 1.31 Bn |
| 238 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.32 Bn | -20.89 | 1.27 | 0.87 Bn |
| 239 | CGEM | Cullinan Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.32 Bn | -6.47 | — | 1.32 Bn |
| 240 | ALMS | Alumis Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.29 Bn | -5.34 | 155.27 | 0.79 Bn |
| 241 | VOR | Vor Biopharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.28 Bn | -1.39 | — | 1.28 Bn |
| 242 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.25 Bn | -172.50 | 0.76 | 0.98 Bn |
| 243 | JANX | Janux Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.24 Bn | -12.05 | 51.49 | 1.24 Bn |
| 244 | AORT | Artivion, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.23 Bn | -390.09 | 2.62 | 1.16 Bn |
| 245 | MNKD | Mannkind Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.22 Bn | -27.97 | 3.10 | 1.11 Bn |
| 246 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.22 Bn | -25.48 | — | 1.00 Bn |
| 247 | STAA | Staar Surgical Co | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.19 Bn | 61.69 | 3.51 | 1.01 Bn |
| 248 | DRTS | Alpha Tau Medical Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.18 Bn | 12.81 | — | 1.08 Bn |
| 249 | JBIO | Jade Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.18 Bn | -7.71 | — | 1.18 Bn |
| 250 | THRM | Gentherm Inc | secondary | I-04 | Machinery | IG-02 | 1.18 Bn | 10.89 | 0.75 | 0.97 Bn |
| 251 | PRCT | PROCEPT BioRobotics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.18 Bn | -10.28 | 3.49 | 0.90 Bn |
| 252 | CLYM | Climb Bio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.18 Bn | -20.47 | — | 1.18 Bn |
| 253 | UTI | Universal Technical Institute Inc | secondary | D-28 | Consumer Services | DG-09 | 1.17 Bn | 33.99 | 1.32 | 1.00 Bn |
| 254 | AVNS | Avanos Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | -15.62 | 1.63 | 1.10 Bn |
| 255 | IMTX | Immatics N.V. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.14 Bn | -4.72 | 23.40 | 0.68 Bn |
| 256 | IRMD | Iradimed Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.07 Bn | 46.54 | 12.39 | 1.01 Bn |
| 257 | MLTX | MoonLake Immunotherapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.04 Bn | -3.92 | — | 0.50 Bn |
| 258 | ABUS | Arbutus Biopharma Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 6.67 | 5.59 | 0.92 Bn |
| 259 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 69.00 | 1.35 | 0.76 Bn |
| 260 | WVE | Wave Life Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.98 Bn | -4.85 | 15.01 | 0.61 Bn |
| 261 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -69.78 | — | 0.91 Bn |
| 262 | INMD | InMode Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.96 Bn | 11.20 | 2.57 | 0.48 Bn |
| 263 | OKYO | OKYO Pharma Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.96 Bn | -118.02 | — | 0.96 Bn |
| 264 | GERN | Geron Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -14.19 | 3.92 | 0.65 Bn |
| 265 | BVS | Bioventus Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.94 Bn | 15.26 | 1.61 | 0.91 Bn |
| 266 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -48.72 | — | 0.93 Bn |
| 267 | ARDX | Ardelyx, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.92 Bn | -16.50 | 2.04 | 0.64 Bn |
| 268 | ANNX | Annexon, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.90 Bn | -4.41 | — | 0.90 Bn |
| 269 | TBPH | Theravance Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.88 Bn | 20.84 | 8.45 | 0.49 Bn |
| 270 | RIGL | Rigel Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.88 Bn | 2.72 | 3.16 | 0.78 Bn |
| 271 | BBNX | Beta Bionics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.85 Bn | -11.60 | 7.11 | 0.67 Bn |
| 272 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.84 Bn | -10.15 | 376.42 | 0.84 Bn |
| 273 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.84 Bn | -10.51 | 101.77 | 0.84 Bn |
| 274 | SIBN | SI-BONE, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.83 Bn | -57.19 | 3.91 | 0.69 Bn |
| 275 | AVTX | Avalo Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.83 Bn | -8.23 | — | 0.83 Bn |
| 276 | STTK | Shattuck Labs, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.82 Bn | -15.17 | 818.91 | 0.82 Bn |
| 277 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.81 Bn | -6.99 | 9.20 | 0.67 Bn |
| 278 | CTMX | CytomX Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.77 Bn | -10.15 | 42.05 | 0.44 Bn |
| 279 | PHAR | Pharming Group N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.77 Bn | -123.63 | 2.31 | 0.61 Bn |
| 280 | ZURA | Zura Bio Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | -6.33 | — | 0.74 Bn |
| 281 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | 12.55 | 5.37 | 0.51 Bn |
| 282 | WOOF | Petco Health & Wellness Company, Inc. | secondary | S-13 | Staples Retail | SG-06 | 0.70 Bn | 28.06 | 0.12 | 0.41 Bn |
| 283 | AURA | Aura Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | -6.24 | — | 0.62 Bn |
| 284 | IRWD | Ironwood Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.67 Bn | 3.02 | 1.72 | 0.59 Bn |
| 285 | SSII | SS Innovations International, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.65 Bn | -42.48 | 12.43 | 0.63 Bn |
| 286 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.09 | 1.71 | 0.38 Bn |
| 287 | ASMB | Assembly Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 512.03 | 8.51 | 0.32 Bn |
| 288 | ANGO | Angiodynamics Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.64 Bn | -17.30 | 1.99 | 0.58 Bn |
| 289 | SLN | Silence Therapeutics plc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -16.33 | 1,032.29 | 0.56 Bn |
| 290 | CBIO | Crescent Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.62 Bn | -3.79 | 595.36 | 0.45 Bn |
| 291 | ALT | Altimmune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -8.32 | — | 0.61 Bn |
| 292 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -344,077.60 | — | 0.60 Bn |
| 293 | BBOT | BridgeBio Oncology Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -2.99 | — | 0.37 Bn |
| 294 | BRSYF | Brainsway Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 60.53 | 9.76 | 0.53 Bn |
| 295 | CTNM | Contineum Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -9.71 | — | 0.59 Bn |
| 296 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,174.84 | 6.08 | 0.48 Bn |
| 297 | TECX | Tectonic Therapeutic, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.58 Bn | -6.73 | — | 0.58 Bn |
| 298 | SGMT | Sagimet Biosciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -11.87 | — | 0.57 Bn |
| 299 | ARVN | Arvinas, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | 61.52 | 1.81 | 0.00 Bn |
| 300 | VALN | Valneva SE | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -9.74 | 3.41 | 0.43 Bn |